Human neutrophil gelatinase-associated apolipoprotein (NGAL)

タイトルまたは説明

Human neutrophil gelatinase-associated apolipoprotein (Neutrophilgelatinase-associated lipocalin, NGAL)
Acute kidney injury (AKI) is a clinical syndrome caused by a decline in kidney function caused by a variety of reasons in a short period of time. So far, AKI is still a very common and serious clinical problem. The lack of specific early clinical diagnostic indicators is the main obstacle to the treatment of the disease, resulting in a high incidence and mortality of AKI. Human neutrophil gelatinase-associated lipocalin (NGAL) is a highly effective new AKI clinical diagnostic marker for early kidney injury. If treated in the early stages of AKI, it can greatly reduce the incidence of renal failure. Therefore, early diagnosis of AKI has become a key factor in the treatment of nephropathy. Cystatin C is currently widely used in clinical diagnosis of early kidney injury. However, in comparison, the diagnostic value of NGAL in the early stage of acute kidney injury is greater than that of cystatin C.
NGAL provided by our company is a human-derived recombinant protein with strong immunogenicity. It can be used as an antigen to prepare high-efficiency NGAL antibodies. It can also be used as a positive control or standard for detection.
Source: Microbial recombinant protein (expressed by E. coli or yeast)
Molecular weight: about *2Kd (SDS-PAGE detection)
Purity:> *0% (SDS-PAGE detection)
Buffer composition: PBS
Storage conditions: The liquid can be stored at 4℃ for about one year, longer-time storage at **0℃ or **0℃, try to avoid repeated freezing and thawing; freeze dried powder can be stored for a long time
Transportation conditions: low temperature
Safety Tips: Not for human experiment